Trial Profile
Predictive value of circulating endothelial cells for efficacy of chemotherapy with Rh-endostatin in non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 19 Sep 2012
Price :
$35
*
At a glance
- Drugs Endostatin (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 19 Sep 2012 New trial record